Was Alpha deadlier than wild-type COVID? Analysis in rural England
Tóm tắt
It is useful to document whether each newly dominant SARS-CoV-2 variant of concern was more or less dangerous than preceding dominant variant(s). We assessed if the emergence of the Alpha (B.1.1.7) variant in autumn 2020 could be linked to higher case fatality rates, compared to original wild-type COVID-19, subgrouping by age band, sex, deprivation or month of diagnosis as potential risk factors.
Observational study and secondary analysis were conducted of SARS-CoV-2 cases diagnosed due to medical need or occupational exposure in an administrative area of Eastern England, UK (base population 1 million), who first tested positive in the period 1 March 2020 to 28 February 2021. Multivariate logistic regression was performed to examine relationships of age group, sex, deprivation group and month of diagnosis with case fatality rates within 28 days of diagnosis. Marginal probabilities for risk of dying were calculated separately for the first two main ‘wave’ periods of the English pandemic.
Older age and male sex consistently raised the risk of mortality in both wave periods. Higher deprivation was linked to mortality risk in the first wave period, but not in the second wave. Mortality decreased over time during the first wave period, but slightly increased over time during the second wave. Cases were younger in the second wave, and median age of the deceased varied little between waves.
The Alpha variant of SARS-CoV-2 did not lead to higher mortality rates for any age, deprivation or sex group, compared to case fatality rates in the early part of the pandemic period.
Từ khóa
Tài liệu tham khảo
WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (2020).Accessed 12 March 2020.
Rajgor DD, Lee MH, Archuleta S, Bagdasarian N, Quek SC. The many estimates of the COVID-19 case fatality rate. Lancet Infect Dis. 2020;20:776–7.
Streeck H, Schulte B, Kuemmerer B, Richter E, Höller T, Fuhrmann C, Bartok E, Dolscheid R, Berger M, Wessendorf L. Infection fatality rate of SARS-CoV-2 infection in a German community with a super-spreading event. Medrxiv. 2020.
Levin AT, Hanage WP, Owusu-Boaitey N, Cochran KB, Walsh SP, Meyerowitz-Katz G. Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications. Eur J Epidemiol. 2020;35:1123–38.
European centre for disease prevention and control. coronavirus disease 2019 (COVID-19) in the EU/EEA and the UK – eighth update.2019;39. https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-rapid-risk-assessment-coronavirus-disease-2019-eighth-update-8-april-2020.pdf. Accessed 8 Apr 2021
Dennis JM, McGovern AP, Vollmer SJ, Mateen BA. Improving survival of critical care patients with coronavirus disease 2019 in England: a national cohort study, march to june 2020. Crit Care Med. 2021;49:209–14.
Little C, Alsen M, Barlow J, Naymagon L, Tremblay D, Genden E, Trosman S, Iavicoli L, van Gerwen M. The impact of socioeconomic status on the clinical outcomes of COVID-19; a retrospective cohort study. J Community Health. 2021;46(4):794–802.
Iacobucci G. COVID-19: New UK variant may be linked to increased death rate, early data indicate. Br M J. 2021. https://doi.org/10.1136/bmj.n230.
McCurdy C. Ageing fast and slow: When place and demography collide.
Brainard J, Rushton SR, Winters T, Hunter PR. Spatial risk factors for Pillar 1 COVID-19 case counts and mortality in rural eastern England, UK. Risk Anal. 2021. https://doi.org/10.1111/risa.13835.
Department of health and social care. Coronavirus (COVID-19) scaling up our testing programmes. Socal Care; 2020. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/878121/coronavirus-covid-19-testing-strategy.pdf
Hofäcker D, Schroeder H, Li Y, Flynn M. Trends and determinants of work-retirement transitions under changing institutional conditions: Germany, England and Japan compared. J Soc Policy. 2016;45:39.
LSOAs, LEPs and lookups : A beginner’s guide to statistical geographies. undated. https://ocsi.uk/2019/03/18/lsoas-leps-and-lookups-a-beginners-guide-to-statistical-geographies/.(2020) Accessed 21 May 2020.
McLennan D, Noble S, Noble M, Plunkett E, Wright G, Gutacker N. The English indices of deprivation 2019: technical report. Ministry of Housing CaLG. 2019
Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. 2020. https://virological.org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined-by-a-novel-set-of-spike-mutations/563. (2021) Accessed 27 Jan 2021.
Norfolk and new variant SARS-CoV-2. 2020. https://quadram.ac.uk/norfolk-and-new-variant-sars-cov-2/#:~:text=A%20new%20variant%20of%20SARS,with%20the%20date%2C%20December%202020.&text=In%20the%20first%20week%20in,in%20the%20community%20in%20Norfolk. (2021) Accessed 27 Jan 2021.
Quality of mortality data during the coronavirus pandemic, England and Wales: 2020. 2020. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/articles/qualityofmortalitydataduringthecoronaviruspandemicenglandandwales/2020. (2021) Accessed 27 Jan 2021.
Bonanad C, Garcia-Blas S, Tarazona-Santabalbina F, Sanchis J, Bertomeu-González V, Facila L, Ariza A, Nunez J, Cordero A. The effect of age on mortality in patients with COVID-19: a meta-analysis with 611,583 subjects. J Am Med Dir Assoc. 2020;21:915–8.
Green MS, Nitzan D, Schwartz N, Niv Y, Peer V. (Sex differences in the case-fatality rates for COVID-19—A comparison of the age-related differences and consistency over seven countries. PLoS ONE. 2021;16:e0250523.
Pidd H, Barr CB, Mohdin A. Calls for health funding to be prioritised as poor bear brunt of COVID-19. The Guardian. 2020.
Davies B, Parkes BL, Bennett J, Fecht D, Blangiardo M, Ezzati M, Elliott P. Community factors and excess mortality in first wave of the COVID-19 pandemic in England. Nat Commun. 2021;12:1–9.
Schroeder A, MacLeod MR. A systematic review of the impact of the alpha and gamma variants of concern on hospitalization and symptomatic rate of SARS-CoV-2. Medrxiv. 2021.
COVID: Who is getting the vaccine next? Who is 'clinically vulnerable'? 2021. https://www.itv.com/news/2021-02-15/covid-who-is-getting-the-vaccine-next-who-is-clinically-vulnerable. (2021) Accessed 28 Apr. 2021
Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE. Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials. The Lancet. 2021;397:881–91.
Hunter PR, Brainard JS. Estimating the effectiveness of the Pfizer COVID-19 BNT162b2 vaccine after a single dose. a reanalysis of a study of'real-world’vaccination outcomes from Israel. Medrxiv. 2021
Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, Azman AS, Reich NG, Lessler J. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020;172:577–82.
Are people letting down their guard too soon after COVID-19 vaccination? 2021. https://blogs.bmj.com/bmj/2021/03/18/are-people-letting-down-their-guard-too-soon-after-covid-19-vaccination/#:~:text=While%20not%20conclusive%2C%20the%20data,degree%20of%20immunity%20has%20developed. (2021) Accessed 28 Apr 2021.
Overview report: Norfolk. https://www.norfolkinsight.org.uk/population/. (2020). Accessed 3 Mar 2022